Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|January 28, 1994
Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3. Lack of modulation by 9-cis-retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivativesJ Ferrara, K McCuaig, G N Hendy, et al.
Journal of Molecular Endocrinology|August 1, 1997
Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherinM J Campbell, E Elstner, S Holden, et al.
Leukemia|August 19, 2005
Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidantQ Wang, J S Harrison, M Uskokovic, et al.
Cancer Research|August 27, 1999
5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cellsJ Hisatake, T Kubota, Y Hisatake, et al.
Cancer Research|August 12, 1998
19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cellsT Kubota, K Koshizuka, M Koike, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1995
Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3B Cheskis, B D Lemon, M Uskokovic, et al.
Biochemical and Biophysical Research Communications|October 31, 1983
1 alpha, 25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skinA W Wood, R L Chang, M T Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograftS R Evans, A M Schwartz, E I Shchepotin, et al.
Anticancer Research|August 5, 2006
Vitamin D and cancerC S Spina, V Tangpricha, M Uskokovic, et al.
International Journal of Oncology|May 17, 2000
1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis modelS R Evans, E I Shchepotin, H Young, et al.
Pageof 4